Services designed around your pathway
Clinical trials aren't one size fits all. This is why Mobius tailors strategies and services to your device while meeting global standards.
How we support your trials
Our services cover the full pathway, from feasibility through to post-market.
You can work with us end-to-end or just where you need us most.
Clinical Trial Strategy
We design studies that are tailored to your goals and budget, while ensuring critical physician interactions to accelerate success.

Clinical Trial Execution
We manage your studies end-to-end keeping your program moving and delivering inspection-ready data.
.png)
Regulatory and Beyond
Align your trial with global regulatory standards built into the strategy from day one.
The highest standard of delivery
More than a CRO. Your MedTech ecosystem.
Every founder has a different starting point. Whether your priority is raising investment, validating feasibility or achieving FDA approval, Mobius builds a pathway tailored to you.
Ensuring your innovation reaches doctors and patients
- Regulatory Strategy
- Reimbursement Strategy
- Market Access Roadmap
- Intellectual Property Road mapping
- Funding and M&A
- Post-Market Surveillance
Generate preliminary evidence and a clear pathway to human trials
- Bench & Lab Testing
- Small & Large Animal Testing
- Cadaver (Wet) Lab Testing
Build a product ready for launch and scaling
- Product Development & Design
- Prototype & Small Batch Manufacturing
- Technical File Development
- Clean Room & Equipment Hire
- MVP & Design Lock
- Scale-Up
- Clinical Engineer Support
Ensure regulatory compliance and engagement across the globe
Regulatory Agency Strategy, engagement & Submission
- Q-Sub/Pre-Sub
- Conformity Assessment
- 13485, 21 CFR 820 QMS Set-Up & Management
- Audits & Quality Assurance
- SOP & Document Development
Get everything you need for a seamless trial
- Pathology Kits
- Core Labs
- Imaging
- Logistics
- IP Storage & Distribution
- IP Compounding
Bolster your go-to-market strategy with clarity
- Medical Policy & Coverage Research
- Payer Research & Gap Analysis
- Coding & Billing
- Health Economics
What partners say about us
Guiding you through what you don’t know yet
We answer the questions you may not even know to ask, from readiness to cost, timelines to regulatory differences, so you can move forward with clarity.
If you’ve completed your prototype, generated pre-clinical data based on a robust risk analysis plan, and defined your intended use, you’re likely ready to explore a first-in-human or feasibility study. We can assess your device, documentation, and regulatory pathway to confirm readiness and define the next steps.
Australia offers globally recognised ICH-GCP/ISO 14155-compliant standards, rapid ethics and regulatory approvals, and generous R&D tax incentives—up to 43% cashback on eligible spend. Data collected here are widely accepted by international regulatory authorities, making it the ideal place to start.
Budgets vary by study size, endpoints, and number of sites. Early feasibility studies with full-service typically range from AUD $250K–$1M; pivotal studies are higher. We tailor budgets to your design and help identify tax and funding offsets.
Running early feasibility or safety studies in Australia allows you to collect high-quality data quickly, which can be used in your FDA IDE or 510(k) submission. This “ANZ-to-US bridge” is one of the most time-efficient routes to market.
Medical device trials focus on performance and safety, not drug pharmacokinetics. They’re usually smaller, faster, and more iterative—requiring deep technical and engineering understanding as well as clinical rigour. Focus is on safety and feasibility of the application or procedure, technical training and user experience whereas in drug trials, controlled exposure for safety and efficacy are paramount.
